A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
Monthly Archives: October, 2018
The longest-serving chair in the department’s history, Schafer will be remembered as an excellent surgeon, a trusted mentor and a visionary leader.
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
Northwestern’s sponsored research awards grew to $702.1 million last fiscal year, the largest amount in the University’s history and a 3.8 percent increase over the previous year’s record-breaking $676.5 million.
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
A Northwestern Medicine study has demonstrated that an age-related increase in estrogen may be the culprit behind a common hernia in elderly men.
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.